ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.906,08
-0,49%
S&P 500
5.942,47
1,26%
Dow Jones
42.732,13
0,80%
Euro vs US Dollar
1,03115
0,00%
Bitcoin
98.324,11
0,12%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Aspira Womans Health Inc (AWH)

  7. Aspira Womans Health Inc (AWH) News

AWH

Aspira Womans Health (AWH)

Aspira Womans Health Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AWH
DatumZeitQuelleÜberschriftSymbolFirma
31/12/202423h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AWHAspira Womans Health Inc
16/12/202423h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AWHAspira Womans Health Inc
16/12/202414h45GlobeNewswire Inc.Aspira Women’s Health Announces Appointment of Dr. Sandra Milligan as Interim CEONASDAQ:AWHAspira Womans Health Inc
03/12/202414h00GlobeNewswire Inc.Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million AwardNASDAQ:AWHAspira Womans Health Inc
23/11/202400h16Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AWHAspira Womans Health Inc
19/11/202422h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AWHAspira Womans Health Inc
14/11/202422h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
14/11/202422h00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:AWHAspira Womans Health Inc
14/11/202421h23Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AWHAspira Womans Health Inc
14/11/202414h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AWHAspira Womans Health Inc
14/11/202414h00GlobeNewswire Inc.Aspira Women’s Health Reports Selected Third Quarter 2024 Financial ResultsNASDAQ:AWHAspira Womans Health Inc
14/11/202402h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
07/11/202414h00GlobeNewswire Inc.Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®NASDAQ:AWHAspira Womans Health Inc
04/11/202414h00GlobeNewswire Inc.Aspira Women’s Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024NASDAQ:AWHAspira Womans Health Inc
29/10/202421h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AWHAspira Womans Health Inc
28/10/202423h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
28/10/202423h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
25/10/202414h00GlobeNewswire Inc.Aspira Women’s Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024NASDAQ:AWHAspira Womans Health Inc
24/10/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AWHAspira Womans Health Inc
23/10/202419h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AWHAspira Womans Health Inc
23/10/202417h23GlobeNewswire Inc.Aspira Women’s Health Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s HealthNASDAQ:AWHAspira Womans Health Inc
18/10/202422h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AWHAspira Womans Health Inc
15/10/202422h05GlobeNewswire Inc.Aspira Women’s Health Receives Approval from New York State Department of Health for OvaWatch®NASDAQ:AWHAspira Womans Health Inc
03/10/202422h44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
03/10/202400h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
02/10/202423h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
02/10/202423h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
02/10/202423h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
02/10/202423h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AWHAspira Womans Health Inc
13/09/202423h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AWHAspira Womans Health Inc
 Showing the most relevant articles for your search:NASDAQ:AWH

Kürzlich von Ihnen besucht

TG
MBG
MercedesBenz
TG
RHM
Rheinmetall
AMEX
XLV
Health Care Select Sector
NASDAQ
TSLA
Tesla
NYSE
KO
Coca Cola
TG
432
Arbor Metals
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
ETHUSD
Ethereum
TG
NOV
Novo Nordisk
NYSE
DIS
Walt Disney
TG
D7G
Nel ASA
AMEX
XLE
Energy Select Sector SPDR
COIN
BTCUSD
Bitcoin
PM
XAUUSD
Gold vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten